US 11090308
Methods of treating liver disorders or lipid disorders with a THR-beta agonist
granted A61KA61K31/53A61P
Quick answer
US patent 11090308 (Methods of treating liver disorders or lipid disorders with a THR-beta agonist) held by Madrigal Pharmaceuticals, Inc. expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Madrigal Pharmaceuticals, Inc.
- Grant date
- Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/53, A61P, A61P1/16, A61P3/06